Neurogene Inc. — Form D
Neurogene Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2020-12-29. The offering totals $115.0M, of which $69.0M was reported sold. Industry: Other.
Offering
- Filed: 2020-12-29
- Form: D
- Accession: 0001567619-20-021637
- Industry: Other
- Exemptions: 06b
- Total offering: $115.0M
- Amount sold: $69.0M
- Remaining: $46.0M
- Investors: 32
- Date of first sale: 2020-12-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-384658
Issuer
- Name: Neurogene Inc.
- CIK: 0001768250
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 535 W. 24th St Fl 5, NEW YORK, NY, 10011
- Phone: 646-921-0610
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Robert Mikail Baffi | Director | New York, NY |
| Stephen Mikail Biggar | Director | New York, NY |
| Cory Mikail Freedland | Director | New York, NY |
| Rachel McMinn | Director | New York, NY |
| Srdjan Mikail Stankovic | Director | New York, NY |
| Caroline Mikail Stout | Director | NEW YORK, NY |
| Christine Mikail Cvijic | Executive Officer | New York, NY |
| Rachel McMinn | Executive Officer | New York, NY |
| Cory Freedland | Director | MENLO PARK, CA |
| Stephen Biggar | Director | New York, NY |
Other filings by this issuer (1)
More